Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension. [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled study evaluated sildenafil in children with pulmonary arterial hypertension; trial completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Arterial Hypertension, Children | Phase 3 | Status: COMPLETED | Results posted: 2009-07-21